(Q48722168)

15 February 2018

title

The new oral adenosine A1 receptor agonist capadenoson in male patients with stable angina. (English)

1 reference

15 February 2018

7

Danuta Czarnecka

1 reference

PubMed ID

22370739

15 February 2018

Kalina Kawecka-Jaszcz

6

Kalina Kawecka-Jaszcz

1 reference

15 February 2018

4

Piotr Ponikowski

1 reference

15 February 2018

1

Michal Tendera

1 reference

15 February 2018

Ewa A Jankowska

5

Ewa Jankowska

1 reference

15 February 2018

Maria Krzemińska-Pakuła

8

Maria Krzemińska-Pakuła

1 reference

15 February 2018

Maciej Sosnowski

10

Maciej Sosnowski

1 reference

15 February 2018

Zofia Parma

3

Zofia Parma

1 reference

15 February 2018

author name string

Ewa Gaszewska-Żurek

2

1 reference

15 February 2018

Zbigniew Bednarkiewicz

9

1 reference

15 February 2018

Michael Ochan Kilama

11

1 reference

15 February 2018

Rahul Agrawal

12

1 reference

15 February 2018

publication date

28 February 2012

1 reference

15 February 2018

Clinical Research in Cardiology

published in

1 reference

15 February 2018

volume

101

1 reference

15 February 2018

issue

7

1 reference

15 February 2018

page(s)

585-591

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s00392-012-0430-8

exact match

0 references

cites work

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

AMP579 is revealed to be a potent A2b-adenosine receptor agonist in human 293 cells and rabbit hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Ivabradine for the treatment of stable angina pectoris in octogenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Influence of heart rate on mortality after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Adenosine receptor agonists: from basic medicinal chemistry to clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Pharmacology and therapeutic applications of A1 adenosine receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Release and actions of adenosine in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

Therapeutic potential of adenosine receptor antagonists and agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0430-8

A1 adenosine receptor agonists and their potential therapeutic applications

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22370739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22370739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22370739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00392-012-0430-8

1 reference

15 February 2018

PubMed ID

22370739

1 reference

15 February 2018